Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$26.13 - $33.94 $52,181 - $67,778
1,997 Added 3.14%
65,653 $1.89 Million
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $6,674 - $7,802
-208 Reduced 0.33%
63,656 $2.11 Million
Q2 2023

Jul 14, 2023

BUY
$36.12 - $41.79 $379,440 - $439,003
10,505 Added 19.69%
63,864 $2.34 Million
Q1 2023

Apr 13, 2023

BUY
$39.39 - $51.28 $720,521 - $938,013
18,292 Added 52.16%
53,359 $2.18 Million
Q4 2022

Jan 12, 2023

SELL
$41.75 - $54.5 $38,243 - $49,922
-916 Reduced 2.55%
35,067 $0
Q3 2022

Oct 27, 2022

SELL
$43.76 - $53.42 $126,597 - $154,544
-2,893 Reduced 7.44%
35,983 $1.58 Million
Q2 2022

Jul 13, 2022

SELL
$46.53 - $55.17 $53,556 - $63,500
-1,151 Reduced 2.88%
38,876 $2.04 Million
Q1 2022

Apr 19, 2022

SELL
$45.75 - $56.69 $186,111 - $230,614
-4,068 Reduced 9.23%
40,027 $2.07 Million
Q4 2021

Jan 12, 2022

BUY
$41.32 - $61.25 $3,222 - $4,777
78 Added 0.18%
44,095 $2.6 Million
Q3 2021

Oct 12, 2021

BUY
$39.25 - $50.42 $270,197 - $347,091
6,884 Added 18.54%
44,017 $1.89 Million
Q2 2021

Jul 20, 2021

BUY
$35.91 - $40.68 $55,265 - $62,606
1,539 Added 4.32%
37,133 $1.45 Million
Q1 2021

Apr 08, 2021

BUY
$33.49 - $37.77 $124,683 - $140,617
3,723 Added 11.68%
35,594 $1.29 Million
Q4 2020

Jan 13, 2021

BUY
$33.47 - $42.56 $229,738 - $292,131
6,864 Added 27.45%
31,871 $1.19 Million
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $482,282 - $565,827
15,190 Added 154.73%
25,007 $918,000
Q2 2020

Jul 22, 2020

BUY
$30.12 - $36.54 $295,688 - $358,713
9,817 New
9,817 $321,000
Q2 2019

Jul 26, 2019

SELL
$36.98 - $41.52 $222,249 - $249,535
-6,010 Closed
0 $0
Q1 2019

Apr 16, 2019

BUY
$37.5 - $41.2 $225,375 - $247,612
6,010 New
6,010 $255,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kmg Fiduciary Partners, LLC Portfolio

Follow Kmg Fiduciary Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kmg Fiduciary Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kmg Fiduciary Partners, LLC with notifications on news.